Home › Funds › Seven Fleet Capital Management LP › ZNTL
Seven Fleet Capital Management LP position in ZNTL
ZENTALIS PHARMACEUTICALS INC · Health Care
Seven Fleet Capital Management LP reported holding 1,504,231 shares of ZNTL (ZENTALIS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 0.81% of its reported portfolio and ranking #21 among its reported holdings. Seven Fleet Capital Management LP has disclosed ZNTL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Seven Fleet Capital Management LP's ZNTL position evolved
Seven Fleet Capital Management LP first disclosed a stake in ZNTL in Q1 2026 at 110,000 shares (US$257K). The position peaked in Q3 2026 at 1,504,231 shares, worth US$4.2M. Across 3 filings, Seven Fleet Capital Management LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,504,231 shares valued at US$4.2M — an increase of 1,186,631 shares quarter over quarter.. Notable position changes include a 189% increase in Q2 2026 (shares fell 43% over the following quarter), a 374% increase in Q3 2026 (shares fell 42% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 110.00K | $257.40K | New |
| Q2 2026 | 317.60K | $1.45M | Add |
| Q3 2026 | 1.50M | $4.17M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZNTL and 13F data
ZNTL (ZENTALIS PHARMACEUTICALS INC) is a Health Care company. 25 other funds we track also report a position in ZNTL — the largest reported positions include 5AM Venture Management, LLC (US$10.9M), Opaleye Management Inc. (US$6.9M), Patient Square Capital LP (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZNTL
- 5AM Venture Management, LLC 3.95M sh · $10.94M · Q3 2026
- Opaleye Management Inc. 1.41M sh · $6.85M · Q2 2026
- Patient Square Capital LP 2.01M sh · $5.56M · Q3 2026
- Decheng Capital LLC 1.32M sh · $3.67M · Q3 2026
- Ishara Investments LP 1.08M sh · $2.99M · Q3 2026
- Boxer Capital Management, LLC 1.01M sh · $2.81M · Q3 2026
- PFIZER INC 953.83K sh · $2.58M · Q3 2026
More on Seven Fleet Capital Management LP
FAQ
How long has Seven Fleet Capital Management LP held ZNTL?
Seven Fleet Capital Management LP has disclosed ZNTL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Seven Fleet Capital Management LP's current position in ZNTL?
As of Q3 2026, Seven Fleet Capital Management LP holds 1.50M shares of ZNTL (ZENTALIS PHARMACEUTICALS INC), valued at $4.17M, representing 0.81% of its reported portfolio and ranking #21.
Has Seven Fleet Capital Management LP been buying or selling ZNTL?
In the latest 13F filing (Q3 2026), Seven Fleet Capital Management LP increased its position in ZNTL. The position peaked in Q3 2026 at 1.50M shares.
Which other funds hold ZNTL?
Other major institutional holders of ZNTL include 5AM Venture Management, LLC, Opaleye Management Inc., Patient Square Capital LP, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.